强制性运动疗法对脑卒中患者下肢运动功能康复的临床分析

目的探讨使用强制性运动疗法(CIMT)对脑卒中偏瘫患者下肢运动功能康复的疗效。方法选取脑卒中偏瘫患者30例,随机分为治疗组和对照组,每组15例。对照组采用常规的物理疗法为主的Bobath技术治疗。治疗组采用CIMT治疗,两组患者均治疗8周。比较两组患者治疗前后10m最大步行速度、Berg平衡量表、简式Fugl-Meyer评价量表中的下肢评价及Barthel指数的变化。结果两组患者治疗前各项指标差异均无统计学意义(P>0.05),两组患者治疗后与治疗前比较,各项功能指标变化差异有统计学意义(P<0.05)。治疗组各项指标明显优于对照组(P<0.05)。结论CIMT改善脑卒中偏瘫患者步行速度和提高日常生活能力具有重要意义。     

人TSH受体胞外段高效表达质粒的构建、表达及蛋白纯化

利用基因重组方法 ,构建hTSHRecd基因片段原核表达系统 (E .coliM15 )。hTSHRecd蛋白表达量大 ,纯化得到毫克级高纯度的hTSHRecd蛋白 ,可与TSHR自身抗体及TSH特异性结合 ,具有免疫活性及一定生物活性     

我院开展临床药学服务的实践与体会

目的交流临床药师参与药学服务时的经验与体会。方法对参与治疗的临床案例在合理用药、提高药物疗效、减少不良反应等方面提出药师意见。结果临床药师参与治疗的案例均取得明显的治疗效果。结论临床药师的工作使医院的合理用药水平得到一定的提高。     

中老年人群糖代谢异常的临床特点分析

目的:探讨中老年人群糖代谢异常的分布情况及其临床特点。方法:测定951例年龄≥45岁人群的身高、体重、腰围、臀围,计算体重指数(BMI)、腰臀比(WHR);口服75g葡萄糖耐量试验确定其糖代谢状态,测定血脂、空腹及餐后2h血浆血糖和血清胰岛素水平,用稳态模型评估法(HOMA)计算胰岛素抵抗(IR)指数(HOMA-IR)、胰岛细胞功能指数(HOMA-β),进行组间比较。结果:①糖耐量正常者(NGT)占53.00%,单纯糖耐量异常(IGT)占25.34%;空腹血糖受损(IFG)占5.15%;IFG合并IGT占3.79%;糖尿病(DM)占12.72%;②IGT、IFG IGT、DM患者的年龄、血压、脉压、BMI显著高于NGT和IFG者;WHR值按NGT、IFG→IGT→IFG IGT、DM的顺序依次增高(P<0.05);IGT、IFG IGT、DM者的三酰甘油(TG)水平高于NGT者(P<0.05),其中隐性糖尿病(LDM)和显性糖尿病(ODM)患者的TG水平又显著高于IFG者(P<0.05);③IR的程度按NGT、IGT→IFG→LDM→IFG IGT→ODM的顺序依次升高;除IGT外,其他糖代谢异常的IR程度均显著高于NGT(P<0.05);HOMA-β按IGT、NGT→LDM→IFG IGT→IFG→ODM的顺序依次降低;各组中以ODM的IR最高,基础胰岛素分泌功能最差。结论:中老年人群的糖代谢异常的患病率高,应重视对餐后血糖的检测,合并有中心性肥胖、高血压等危险因素者建议做口服葡萄糖耐量试验以明确诊断。中老年人群中糖代谢异常者普遍存在IR及胰岛β细胞分泌功能不足。     

性别差异对Graves病动物模型建立的影响

目的 在雌性或雄性BALB/c小鼠制备Graves病动物模型,观察其促甲状腺素受体抗体(TRAb)滴度,TT4水平以及甲状腺组织的增生情况,探讨性别差异对成模的影响.方法 用表达TSH受体A亚单位的重组腺病毒免疫雌性或雄性BALB/c小鼠诱导Graves病,每3周免疫1次,共3次,末次免疫后4周取血,检测TRAb、TT4,剥离甲状腺行组织学检查.结果 雌性和雄性实验组小鼠TRAb阳性率均达到100%,两组之间抗体滴度无显著性差异.雌性及雄性实验组分别有75.0%,41.7%的小鼠发生甲亢,雌性实验组TT4水平明显高于雄性实验组并有统计学差异(P＜0.01),各组甲亢小鼠甲状腺组织出现明显增生.结论 利用表达TSH受体A亚单位的重组腺病毒免疫雌性、雄性BALB/c小鼠诱导Graves病动物模型,尽管两性TRAb抗体水平相似,但其甲亢发生率及程度存在一定的性别偏倚,提示雌性小鼠更易于模型的诱导.

Abstract：

Objective To investigate the effect of mice gender on the TSH receptor antibody(TRAb)titers, the levels of TT4,and the degree of thyroid hyperplasia by establishing an animal model of Graves′ disease in male and female BALB/c mice. Methods Male and female BALB/c mice were immunized with recombinant adenovirus expressing TSHRA subunit(Ad-TSHR289)to induce Graves′ disease. Animals were injected 3 times at intervals of 3 weeks. All mice were sacrificed 4 weeks after the last injection to obtain blood for measurement of TSHR antibody titers and TT4evels, and thyroid glands for histological examination. Results TRAb positive rates were 100% both in female or male mice. No significant difference was observed in titers of TRAb between them. The incidence of hyperthyroidism in female mice was higher than that in male mice, being 75.0% and 41.7% respectively. There was statistical difference in levels of TT4between females and males(P＜0.01). Mice with high TT4exihibited marked thyroid hyperplasia. Conclusion Despite TSHR antibodies were similar between female and male mice, the incidence and degree of hyperthyroidism showed sex bias in Graves′s animal model. The results indicated that it was easier to induce model in females than in males by immunizing BALB/c mice with Ad-TSHR289.     

Graves病药物治疗停药复发相关因素分析

Objective To explore the value of thyroid-stimulating antibody(TSAb) and degree of goiter in predicting the outcome of Graves'disease after antithyroid drug treatment. Methods Seventy-one patients with Graves'disease were given antithyroid drugs for (2. 8±1. 4)years and then followed up for(22±6.0)months.Finally,age,gender,thyroid function,TSAb and goiter size at the time of drug withdrawal were compared between the relapsed and relieved groups. TSAb was measured in all patients by using HEK-hTSHR cells. Results Eleven of 71 patients relapsed during the follow-up after drug withdrawal. The relapse rate (42. 9% ,6/14)in patients with positive TSAb was significantly higher than that (8.8%, 5/57) in patient with negative TSAb (X2 = 9.97, P<0.01). The relapse rates in patients with normal size thyroid, Ⅰ degree goiter,Ⅱ degree goiter were 6.25%, 12.2%,35.7% respectively. TSAb activity, positive rate and goiter size of the relapsed patients at the time of drug withdrawal were significantly higher than those of relieved patients (P<0.05 or P<0. 01). Conclusion TSAb activity and goiter size at the time of drug withdrawal are two effective prognostic markers of relapse in Graves' disease treated with antithyroid drugs.     

联合检测GAD-Ab、ICA对1型糖尿病的诊断和预测价值

研究了儿童1型糖尿病（TIDM）（n=18），LADA（n=23），疑似LADA（n=46），TIDM患者的1级亲属（n=34）和正常对照（n=30），结果显示：联合分析ELISA检测的GAD-Ab和免疫组化检测的IC-Ab，有助于TIDM和LADA的诊断和筛查。     

Graves病药物治疗停药复发相关因素分析

Objective To explore the value of thyroid-stimulating antibody(TSAb) and degree of goiter in predicting the outcome of Graves'disease after antithyroid drug treatment. Methods Seventy-one patients with Graves'disease were given antithyroid drugs for (2. 8±1. 4)years and then followed up for(22±6.0)months.Finally,age,gender,thyroid function,TSAb and goiter size at the time of drug withdrawal were compared between the relapsed and relieved groups. TSAb was measured in all patients by using HEK-hTSHR cells. Results Eleven of 71 patients relapsed during the follow-up after drug withdrawal. The relapse rate (42. 9% ,6/14)in patients with positive TSAb was significantly higher than that (8.8%, 5/57) in patient with negative TSAb (X2 = 9.97, P<0.01). The relapse rates in patients with normal size thyroid, Ⅰ degree goiter,Ⅱ degree goiter were 6.25%, 12.2%,35.7% respectively. TSAb activity, positive rate and goiter size of the relapsed patients at the time of drug withdrawal were significantly higher than those of relieved patients (P<0.05 or P<0. 01). Conclusion TSAb activity and goiter size at the time of drug withdrawal are two effective prognostic markers of relapse in Graves' disease treated with antithyroid drugs.     

玉树地震救援中高原卫勤保障存在的问题与对策

在高原特殊环境下进行的玉树地震救援，救援队伍面临高原环境的威胁，自身卫勤保障面临挑战，其存在的问题是保障观念滞后、准备不足、能力欠缺和体系不全等方面。本研究根据我军高原卫勤保障实践积累和高原医学研究成果提出全面管理，科学筹备，把握关键，体系防护等对策。